Skip to main content
. Author manuscript; available in PMC: 2013 Mar 5.
Published in final edited form as: Breast Cancer Res Treat. 2009 Jan 10;117(2):319–324. doi: 10.1007/s10549-008-0282-0

Fig 1.

Fig 1

Cumulative incidence for competing causes of failure according to estrogen receptor subpopulations for Trial III (a,b) and Trials III plus IV combined (c,d).